These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12467644)

  • 21. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
    Kim HG; Miller DM
    Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triplex formation on DNA targets: how to choose the oligonucleotide.
    Vekhoff P; Ceccaldi A; Polverari D; Pylouster J; Pisano C; Arimondo PB
    Biochemistry; 2008 Nov; 47(47):12277-89. PubMed ID: 18954091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator conjugates targeted to HIV proviral DNA.
    Giovannangeli C; Perrouault L; Escudé C; Nguyen T; Hélène C
    Biochemistry; 1996 Aug; 35(32):10539-48. PubMed ID: 8756710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures.
    Pabon-Martinez YV; Xu Y; Villa A; Lundin KE; Geny S; Nguyen CH; Pedersen EB; Jørgensen PT; Wengel J; Nilsson L; Smith CIE; Zain R
    Sci Rep; 2017 Sep; 7(1):11043. PubMed ID: 28887512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic study of the binding of triplex-forming oligonucleotides containing partial cationic modifications to double-stranded DNA.
    Hari Y; Ijitsu S; Akabane-Nakata M; Yoshida T; Obika S
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3046-9. PubMed ID: 24865415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triplex-forming oligonucleotides can modulate aquaporin-5 gene expression in epithelial cells.
    Delporte C; Panyutin IG; Sedelnikova OA; Lillibridge CD; O'Connell BC; Baum BJ
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):523-9. PubMed ID: 9361911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cooperative interaction of triplex forming oligonucleotides on DNA-triplex formation at electrode surface: Molecular dynamics studies and experimental evidences.
    Petralia S; Forte G; Zimbone M; Conoci S
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110648. PubMed ID: 31767411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of bioactive triple helix-forming oligonucleotides.
    Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R
    Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple helix formation and the antigene strategy for sequence-specific control of gene expression.
    Praseuth D; Guieysse AL; Hélène C
    Biochim Biophys Acta; 1999 Dec; 1489(1):181-206. PubMed ID: 10807007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene targeting via triple-helix formation.
    Casey BP; Glazer PM
    Prog Nucleic Acid Res Mol Biol; 2001; 67():163-92. PubMed ID: 11525382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions.
    Obika S; Hari Y; Sekiguchi M; Imanishi T
    Chemistry; 2002 Oct; 8(20):4796-802. PubMed ID: 12561120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.
    Paramasivam M; Cogoi S; Filichev VV; Bomholt N; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2008 Jun; 36(10):3494-507. PubMed ID: 18456705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Lack of Mutagenic Potential of a Guanine-Rich Triplex Forming Oligonucleotide in Physiological Conditions.
    Saleh AF; Fellows MD; Ying L; Gooderham NJ; Priestley CC
    Toxicol Sci; 2017 Jan; 155(1):101-111. PubMed ID: 27660205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of triple helix forming oligonucleotides to sites in gene promoters.
    Durland RH; Kessler DJ; Gunnell S; Duvic M; Pettitt BM; Hogan ME
    Biochemistry; 1991 Sep; 30(38):9246-55. PubMed ID: 1892832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of transcription and antiproliferative effects in a cancer cell line using antigene oligonucleotides containing artificial nucleoside analogues.
    Wang L; Notomi R; Sasaki S; Taniguchi Y
    RSC Med Chem; 2023 Aug; 14(8):1482-1491. PubMed ID: 37593572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable and Selective Antiparallel Type Triplex DNA Formation by Targeting a GC Base Pair with the TFO Containing One N
    Taniguchi Y; Miyazaki M; Matsueda N; Wang L; Okamura H; Sasaki S
    Chem Pharm Bull (Tokyo); 2018; 66(6):624-631. PubMed ID: 29863064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted gene modification using triplex-forming oligonucleotides.
    Kuan JY; Glazer PM
    Methods Mol Biol; 2004; 262():173-94. PubMed ID: 14769962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts.
    Joseph J; Kandala JC; Veerapanane D; Weber KT; Guntaka RV
    Nucleic Acids Res; 1997 Jun; 25(11):2182-8. PubMed ID: 9153319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In silico search of DNA drugs targeting oncogenes.
    Papadakis G; Gizeli E
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(6):1826-30. PubMed ID: 23221090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triplex forming oligonucleotides--tool for gene targeting.
    Mojzísek M
    Acta Medica (Hradec Kralove); 2004; 47(3):151-6. PubMed ID: 15568730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.